An appeal to humanity: Legal victory in favour of North America's only supervised injection facility: Insite

Harm Reduction Journal

Volumn 7, Issue , 2010, Pages

  Small, Dan ^a,b  

^a PHS Community Services Society Vancouver   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANADA; COURT; DECISION MAKING; DRUG ABUSE; DRUG DEPENDENCE; DRUG DETOXIFICATION; GOVERNMENT; HEALTH CARE FACILITY; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN RIGHTS; INFECTION RISK; NORTH AMERICA; SUBSTANCE ABUSE;

EID: 77957562695     PISSN: None     EISSN: 14777517     Source Type: Journal    
DOI: 10.1186/1477-7517-7-23     Document Type: Article

References (40)

1. Small D. Looking in the cultural mirror: addiction, secret lives and lost personhood. Visions Journal 2005, 2:29-30.
2. Small D. Fools rush in where angels fear to tread: Playing God with Vancouver's supervised injection facility. International Journal of Drug Policy 2007, 18:18-26. 10.1016/j.drugpo.2006.12.013, 17689340.
3. Canada Standing Committee on Health: Transcript of Meeting Thursday, May 29, 2008. 2008, Ottawa: Government of Canada, Health SCo, Canada.
4. Galloway G. Clement seeks appeal of Insite decision. Globe and Mail 2008, Toronto: CTV globe media.
5. Gifford SM. The Meaning of Lumps: A Case Study of the Ambiguities of Risk. Anthropology and Epidemiology 1986, 213-246. D. Reidel Publishing Company, Janes CR.
6. Small D. Fighting addiction's death row: British Columbia Supreme Court Justice Ian Pitfield shows a measure of legal courage. Harm Reduction Journal 2008, 5:1-18. 10.1186/1477-7517-5-1, 18215317.
7. Pitfield THMJ. PHS Community Services Society v. Attorney General of Canada, 2008 BCSC 661. 2008, The Supreme Court of British Columbia.
8. Small D. Amazing grace: Vancouver's supervised injection facility granted six-month lease on life. Harm Reduction Journal 2008, 5:1-6. 10.1186/1477-7517-5-1, 2238741, 18215317.
9. DeBeck K, Wood E, Zhang R, Tyndall M, Montaner J, Kerr T. Police and public health partnerships: Evidence from the evaluation of Vancouver's supervised injection facility. Substance Abuse Treatent, Prevention and Policy 2008, 3:1-5.
10. Fairburn N, Small W, Shannon K, Wood E, Kerr T. Women's Experiences in North America's First Medically Supervised Safer Injection Facility. Social Science and Medicine Forthcoming
11. Kerr T, Kimber J, DeBeck K, Wood E. The Role of Safer Injection Facilities in the Response to HIV/AIDS Among Injection Drug Users. Current HIV/AIDS Reports 2007, 4:158-164. 10.1007/s11904-007-0023-8, 18366946.
12. Kerr T, Small W, Moore D, Wood E. A Micro-Environmental Intervention to Reduce Harms Associated with Drug-Related Overdose: Evidence from the Evaluation of Vancouver's Safer Injection Facility. International Journal of Drug Policy 2007, 18:37-45. 10.1016/j.drugpo.2006.12.008, 17689342.
13. Kerr T, Stoltz J, Tyndall M, Li K, Zhang R, Montaner J, Wood E. Impact of a Medically Supervised Safer Injection Facility on Community Drug Use Patterns: A Before and After Study. British Medical Journal 2006, 332:220-222. 10.1136/bmj.332.7535.220, 1352057, 16439401.
14. Kerr T, Tyndall MW, Lai C, Montaner JSG, Wood E. Drug-Related Overdoses Within A Medically Supervised Safer Injection Facility. International Journal of Drug Policy 2006, 17:436-441.
15. Kerr T, Tyndall MW, Lai C, Montaner JSG, Wood E. Circumstances of First Injection Among Illicit Drug Users Accessing a Medically Supervised Safer Injecting Facility. American Journal of Public Health 2007, 97:1228-1220. 10.2105/AJPH.2006.086256, 1913080, 17538061.
16. Kerr T, Tyndall MW, Li K, Montaner JS, Wood E. Safer Injecting Facility Use and Syringe Sharing Among Injection Drug Users. Lancet 2005, 366:316-318. 10.1016/S0140-6736(05)66475-6, 16039335.
17. Kerr T, Wood E, Small D, Palepu A, Tyndall MW. Potential Use of Safer Injecting Facilities Among Injection Drug Users in Vancouver's Downtown Eastside. Canadian Medical Association Journal 2003, 169:1-5.
18. McKnight I, Maas B, Wood E, Tyndall MW, Small W, Lai C, Montaner JSG, Kerr T. Factors Associated with Public Injecting Among Users of Vancouver's Supervised Injection Facility. American Journal of Drug and Alcohol Abuse 2007, 33:319-325. 10.1080/00952990601175102, 17497555.
19. Milloy MJ, Wood E, Small W, Tyndall M, Lai C, Montaner J, Kerr T. Incarceration experiences in a cohort of active injection drug users. Drug and Alcohol Review 2008, 1-7.
20. Petrar S, Kerr T, Tyndall MW, Zhang R, McKnight B, Montaner JSG, Wood E. Injection Drug Users' Perceptions Regarding Use of a Medically Supervised Safer Injecting Facility. Addictive Behaviors 2007, 32:1088-1093. 10.1016/j.addbeh.2006.07.013, 16930849.
21. Stoltz JA, Wood E, Small W, Li K, Tyndall M, Montaner J, Kerr T. Changes in injecting practices associated with the use of a medically supervised injection facility. Journal of Public Health (Oxford) 2007, 29:35-39.
22. Tyndall MW, Kerr T, Zhang R, King E, Montaner JG, Wood E. Attendance, Drug Use Patterns, and Referrals Made From North America's First Supervised Injection Facility. Drug and Alcohol Dependence 2005, 83:193-198. 10.1016/j.drugalcdep.2005.11.011, 16356659.
23. Tyndall MW, Wood E, Zhang R, Lai C, Montaner JS, Kerr T. HIV Sero-prevalence Among Participants at a Supervised Injection Facility in Vancouver, Canada: Implications for Prevention, Care and Treatment. Harm Reduction Journal 2006, 3:1-5. 10.1186/1477-7517-3-36, 1368973, 16403229.
24. Wood E, Kerr T, Buchner C, Marsh D, Montaner JS, Tyndall MW. Methodology for Evaluating Insite: Canada's First Medically Supervised Safer Injection Facility for Injection Drug Users. Harm Reduction Journal 2004, 1:1-5. 10.1186/1477-7517-1-9, 416562, 15169546.
25. Wood E, Kerr T, Montaner JS, Strathdee S, Kerr T, Wodak A, Spittal P, Hankins C, Schechter MT, Tyndall M. Rationale For Evaluating North America's First Medically Supervised Injecting Facility. Lancet Infectious Diseases 2004, 4:301-306. 10.1016/S1473-3099(04)01006-0, 15120347.
26. Wood E, Kerr T, Small W, Li K, Marsh D, Montaner JS, Tyndall MW. Changes In Public Order After The Opening of a Medically Supervised Safer Injection Facility for Injection Drug Users. Canadian Medical Association Journal 2004, 171:731-734. 10.1503/cmaj.1040774, 517857, 15451834.
27. Wood E, Kerr T, Stoltz J, Qui Z, Zhang R, Montaner JSG, Tyndall MW. Prevalence and correlates of hepatitis C among users of North America's first medically supervised safer injection facility. Public Health 2005, 119:1111-1115. 10.1016/j.puhe.2005.05.006, 16214189.
28. Wood E, Kerr T, Tyndall MW, Montaner JSG. The Canadian government's treatment of scientific process and evidence: Inside the evaluation of North America's first supervised injecting facility. The International Journal of Drug Policy 2007, 1-6.
29. Wood E, Montaner JS, Kerr T. Reflection and Reaction: Illicit drug addiction, infection disease spread, and the need for an evidence-based response. Lancet 2008, 8:142-143.
30. Wood E, Tyndall MW, Lai C, Montaner JSG, Kerr T. Impact of a Medically Supervised Safer Injecting Facility on Drug Dealing and Other Drug-Related Crime. Substance Abuse Treatment, Prevention and Policy 2006, 1:1-4.
31. Wood E, Tyndall MW, Li K, Lloyd-Smith E, Small W, Montaner JSG, Kerr T. Do Supervised Injecting Facilities Attract Higher-Risk Injection Drug Users?. American Journal of Preventive Medicine 2005, 29:126-130. 10.1016/j.amepre.2005.04.011, 16005809.
32. Wood E, Tyndall MW, Montaner JS, Kerr T. Summary of findings from the evaluation of a pilot medically supervised injecting facility. Canadian Medical Association Journal 2006, 175:1399-1404. 10.1503/cmaj.060863, 1635777, 17116909.
33. Wood E, Tyndall MW, Qui Z, Zhang R, Montaner JS, Kerr T. Service Uptake and Characteristics of Injection Drug Users Utilizing North America's First Medically Supervised Safer Injection Facility. American Journal of Public Health 2006, 96:770-773. 10.2105/AJPH.2004.057828, 1470579, 16571703.
34. Wood E, Tyndall MW, Stoltz J, Small W, Lloyd-Smith E, Zhang R, Montaner JSG, Kerr T. Factors Associated with Syringe Sharing Among Users of a Medically Supervised Injecting Facility. American Journal of Infectious Diseases 2005, 1:50-54.
35. Wood E, Tyndall MW, Stoltz J, Small W, Zhang R, O'Connell J, Montaner JSG, Kerr T. Safer Injecting Education for HIV Prevention Within a Medically Supervised Safer Injecting Facility. International Journal of Drug Policy 2005, 16:281-284.
36. Wood E, Tyndall MW, Zhang R, Stoltz J, Lai C, Montaner JSG, Kerr T. Attendance at Supervised Injecting Facilities and Use of Detoxification Services. New England Journal of Medicine 2006, 354:2512-2514. 10.1056/NEJMc052939, 16760459.
37. Wood E, Tyndall MW, Zhang R, Montaner JS, Kerr T. Rate of detoxification service use and its impact among a cohort of supervised injection facility users. Addiction 2007, 102:916-919. 10.1111/j.1360-0443.2007.01818.x, 17523986.
38. Wood RA, Wood E, Lai C, Tyndall MW, Montaner JSG, Kerr T. Nurse-delivered safer injection education among a cohort of injection drug users: Evidence from the evaluation of Vancouver's supervised injection facility. International Journal of Drug Policy 2008, 19:183-188. 10.1016/j.drugpo.2008.01.003, 18367389.
39. Hwang SW. Science and ideology. Open Medicine 2007, 1:E99-101. 2802009, 20101301.
40. Hall N. Federal government appeals ruling on safe-injection site to nation's top court. Vancouver Sun 2010, Vancouver: Canwest Publishing.